Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The 8 mg variant is the highest concentration in the line chosen for research protocols requiring high working molarities at a minimal source volume
SINERGIA CON EVOLOCUMAB El evolocumab es un anticuerpo monoclonal inhibidor de la PCSK-9 de administracin subcutnea (quincenal o mensual) que ha consolidado su relevancia clnica tras demostrar una potente reduccin del colesterol unido a lipoprotenas de baja densidad ( c-LDL )
During treatment Follow proper injection protocol
First, the 2.5 mg starting dose is not therapeutic
US$ 22.29
US$ 23.35
US$ 27.83
US$ 20.94
